Literature DB >> 2974620

Increasing the functional residual capacity may reverse obstructive sleep apnea.

F Sériès1, Y Cormier, N Lampron, J La Forge.   

Abstract

We describe the reversal of obstructive sleep apnea with a 0.5 L increase in the functional residual capacity (FRC) in a patient with sleep apnea syndrome. The patient had been treated with medroxyprogesterone acetate for 8 months. The increase in FRC was obtained by applying a constant negative extrathoracic pressure (NEP) with a poncho-type respirator. With pulmonary inflation, there was a dramatic decrease in the apnea index and the percent apnea time, and an improvement in sleep architecture. At all sleep stages, the desaturation duration was shorter with NEP. The exact mechanisms by which pulmonary expansion improved sleep apnea in this patient remain unclear; lung volume dependence of upper airway patency and the improvements in apnea-induced desaturation may be contributing factors. Our observation illustrates that lung volumes may be an important factor in the pathophysiology of obstructive sleep apnea, especially in the apnea onset and in the apneic-induced desaturation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974620

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  10 in total

1.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

2.  Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children.

Authors:  Brian McGinley; Ann Halbower; Alan R Schwartz; Philip L Smith; Susheel P Patil; Hartmut Schneider
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

3.  How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?

Authors:  Charalampos Mermigkis; Eleni Stagaki; Stavros Tryfon; Sophia Schiza; Anastasia Amfilochiou; Vlassios Polychronopoulos; Panagiotis Panagou; Nikolaos Galanis; Anastasios Kallianos; Demetrios Mermigkis; Antony Kopanakis; Georgios Varouchakis; Fotis Kapsimalis; Demosthenis Bouros
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

4.  Autoadjusting positive pressure trial in adults with sleep apnea assessed by a simplified diagnostic approach.

Authors:  Luis Torre-Bouscoulet; María Sonia Meza-Vargas; Armando Castorena-Maldonado; Margarita Reyes-Zúñeiga; Rogelio Pérez-Padilla
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

5.  Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea.

Authors:  R C Heinzer; M L Stanchina; A Malhotra; A S Jordan; S R Patel; Y-L Lo; A Wellman; K Schory; L Dover; D P White
Journal:  Thorax       Date:  2006-02-20       Impact factor: 9.139

6.  A nasal cannula can be used to treat obstructive sleep apnea.

Authors:  Brian M McGinley; Susheel P Patil; Jason P Kirkness; Philip L Smith; Alan R Schwartz; Hartmut Schneider
Journal:  Am J Respir Crit Care Med       Date:  2007-03-15       Impact factor: 21.405

7.  Obstructive sleep apnea is common in patients with interstitial lung disease.

Authors:  Aylin Pihtili; Zuleyha Bingol; Esen Kiyan; Caglar Cuhadaroglu; Halim Issever; Ziya Gulbaran
Journal:  Sleep Breath       Date:  2013-04-08       Impact factor: 2.816

8.  What can impulse oscillometry and pulmonary function testing tell us about obstructive sleep apnea: a case-control observational study?

Authors:  Arikiny Abdeyrim; NanFang Li; Liang Shao; Mulalibieke Heizhati; Yingchun Wang; Xiaoguang Yao; Suofeiya Abulikemu; Delian Zhang; Guijuan Chang; Ting Yin; Cai Li; Jing Meng; MingHua Zhao; Ling Zhou; Jing Hong; Yongping Zhang
Journal:  Sleep Breath       Date:  2015-05-10       Impact factor: 2.816

Review 9.  Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.

Authors:  Ayodeji Adegunsoye; Jay Balachandran
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

10.  Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment.

Authors:  Ana Verónica Cardoso; Nuno Pereira; Inês Neves; Vanessa Santos; José Miguel Jesus; Natália Melo; Patrícia Caetano Mota; António Morais; Marta Drummond
Journal:  Can J Respir Ther       Date:  2018-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.